189 related articles for article (PubMed ID: 32439961)
1. PPARδ-mediated mitochondrial rewiring of osteoblasts determines bone mass.
Müller DIH; Stoll C; Palumbo-Zerr K; Böhm C; Krishnacoumar B; Ipseiz N; Taubmann J; Zimmermann M; Böttcher M; Mougiakakos D; Tuckermann J; Djouad F; Schett G; Scholtysek C; Krönke G
Sci Rep; 2020 May; 10(1):8428. PubMed ID: 32439961
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.
Dvorak-Ewell MM; Chen TH; Liang N; Garvey C; Liu B; Tu C; Chang W; Bikle DD; Shoback DM
J Bone Miner Res; 2011 Dec; 26(12):2935-47. PubMed ID: 21956637
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.
Wang P; Liu J; Li Y; Wu S; Luo J; Yang H; Subbiah R; Chatham J; Zhelyabovska O; Yang Q
Circ Res; 2010 Mar; 106(5):911-9. PubMed ID: 20075336
[TBL] [Abstract][Full Text] [Related]
5. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
6. Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development.
Robinson LJ; Mancarella S; Songsawad D; Tourkova IL; Barnett JB; Gill DL; Soboloff J; Blair HC
Lab Invest; 2012 Jul; 92(7):1071-83. PubMed ID: 22546867
[TBL] [Abstract][Full Text] [Related]
7. Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/δ in osteoblasts.
Chabbi-Achengli Y; Launay JM; Maroteaux L; de Vernejoul MC; Collet C
PLoS One; 2013; 8(9):e75783. PubMed ID: 24069449
[TBL] [Abstract][Full Text] [Related]
8. Tissue inhibitor of metalloproteinase 1 suppresses growth and differentiation of osteoblasts and differentiation of osteoclasts by targeting the AKT pathway.
Xi Y; Huang H; Zhao Z; Ma J; Chen Y
Exp Cell Res; 2020 Apr; 389(2):111930. PubMed ID: 32113948
[TBL] [Abstract][Full Text] [Related]
9. Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function.
Tsang K; Liu H; Yang Y; Charles JF; Ermann J
Bone; 2019 Apr; 121():172-180. PubMed ID: 30659979
[TBL] [Abstract][Full Text] [Related]
10. The role of osteoblasts in energy homeostasis.
Dirckx N; Moorer MC; Clemens TL; Riddle RC
Nat Rev Endocrinol; 2019 Nov; 15(11):651-665. PubMed ID: 31462768
[TBL] [Abstract][Full Text] [Related]
11. Chondrocyte FGFR3 Regulates Bone Mass by Inhibiting Osteogenesis.
Wen X; Li X; Tang Y; Tang J; Zhou S; Xie Y; Guo J; Yang J; Du X; Su N; Chen L
J Biol Chem; 2016 Nov; 291(48):24912-24921. PubMed ID: 27729453
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanisms of osteoblast and osteoclast differentiation.
Katagiri T; Takahashi N
Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
[TBL] [Abstract][Full Text] [Related]
13. Loss of phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) in mesenchymal stem cells leads to osteopenia by impairing bone remodeling.
Yan Q; Gao H; Yao Q; Ling K; Xiao G
J Biol Chem; 2022 Mar; 298(3):101639. PubMed ID: 35090892
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Cell-Derived Juxtacrine Wnt1 Signaling Regulates Osteoblast Activity and Osteoclast Differentiation.
Wang F; Tarkkonen K; Nieminen-Pihala V; Nagano K; Majidi RA; Puolakkainen T; Rummukainen P; Lehto J; Roivainen A; Zhang FP; Mäkitie O; Baron R; Kiviranta R
J Bone Miner Res; 2019 Jun; 34(6):1129-1142. PubMed ID: 30690791
[TBL] [Abstract][Full Text] [Related]
15. Energy Metabolism During Osteogenic Differentiation: The Role of Akt.
Smith CO; Eliseev RA
Stem Cells Dev; 2021 Feb; 30(3):149-162. PubMed ID: 33307974
[TBL] [Abstract][Full Text] [Related]
16. Commensal Microbiota Enhance Both Osteoclast and Osteoblast Activities.
Uchida Y; Irie K; Fukuhara D; Kataoka K; Hattori T; Ono M; Ekuni D; Kubota S; Morita M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29937485
[TBL] [Abstract][Full Text] [Related]
17. PIP5k1β controls bone homeostasis through modulating both osteoclast and osteoblast differentiation.
Zhao X; Cui P; Hu G; Wang C; Jiang L; Zhao J; Xu J; Zhang X
J Mol Cell Biol; 2020 Jan; 12(1):55-70. PubMed ID: 30986855
[TBL] [Abstract][Full Text] [Related]
18. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma regulates bone remodeling after midpalatal suture expansion in mice.
Wu J; Ru N; Li S
Int J Oral Maxillofac Implants; 2015; 30(6):1423-30. PubMed ID: 26478981
[TBL] [Abstract][Full Text] [Related]
20. Bcl6 promotes osteoblastogenesis through Stat1 inhibition.
Fujie A; Funayama A; Miyauchi Y; Sato Y; Kobayashi T; Kanagawa H; Katsuyama E; Hao W; Tando T; Watanabe R; Morita M; Miyamoto K; Kanaji A; Morioka H; Matsumoto M; Toyama Y; Miyamoto T
Biochem Biophys Res Commun; 2015 Feb; 457(3):451-6. PubMed ID: 25597995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
